Page 8 - Nyse Path News Today

UiPath (NYSE:PATH – Get Rating) is set to post its quarterly earnings results after the market closes on Wednesday, May 24th. Analysts expect UiPath to post earnings of $0.02 per share for the quarter. UiPath has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual interested in participating in the […]

UiPath Inc. (NYSE:PATH – Get Rating) rose 5.4% during trading on Monday . The stock traded as high as $16.37 and last traded at $16.32. Approximately 1,038,883 shares changed hands during trading, a decline of 83% from the average daily volume of 5,955,604 shares. The stock had previously closed at $15.49. Wall Street Analysts Forecast […]

Mirae Asset Global Investments Co. Ltd. lessened its holdings in UiPath Inc. (NYSE:PATH – Get Rating) by 5.1% in the fourth quarter, HoldingsChannel reports. The fund owned 3,111,344 shares of the healthcare company’s stock after selling 168,014 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in UiPath were worth $39,545,000 as of […]

Motley Fool Asset Management LLC purchased a new stake in UiPath Inc. (NYSE:PATH – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,228 shares of the healthcare company’s stock, valued at approximately $143,000. Several other institutional investors […]

Liberty Mutual Group Asset Management Inc. purchased a new stake in shares of UiPath Inc. (NYSE:PATH – Get Rating) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 23,198 shares of the healthcare company’s stock, valued at approximately $295,000. Other institutional investors have also recently made changes […]

Fox Run Management L.L.C. purchased a new position in shares of UiPath Inc. (NYSE:PATH – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 33,009 shares of the healthcare company’s stock, valued at approximately $420,000. A number of other […]

Shares of UiPath Inc. (NYSE:PATH – Get Rating) have received a consensus rating of “Moderate Buy” from the nineteen research firms that are presently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target […]

UiPath Inc. (NYSE:PATH – Get Rating) has been given an average recommendation of “Moderate Buy” by the nineteen brokerages that are covering the company, Marketbeat reports. Six analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price target among brokerages that have […]

Phoenix Wealth Advisors cut its holdings in UiPath Inc. (NYSE:PATH – Get Rating) by 12.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,471 shares of the healthcare company’s stock after selling 2,418 shares during the quarter. Phoenix Wealth Advisors’ holdings […]

DA Davidson began coverage on shares of UiPath (NYSE:PATH – Get Rating) in a report issued on Thursday morning, The Fly reports. The brokerage issued a neutral rating and a $16.00 target price on the healthcare company’s stock. PATH has been the subject of several other reports. Needham & Company LLC reissued a buy rating […]